CD4+T cells purified from macaque PBMC were cultured 6 days before being infected with SIV using ViroMag.
This paper shows the efficiency of ViroMag from OZ Biosciences to enhance infection and transduction in primary CD4+ T lymphocytes from macaques.article reference: PLoS One. 2014 Mar 20;9(3):e92012.
Vaccination against Endogenous Retrotransposable Element Consensus Sequences Does Not Protect Rhesus Macaques from SIVsmE660 Infection and Replication.
Sheppard NC, Jones RB, Burwitz BJ, Nimityongskul FA, Newman LP, Buechler MB, Reed JS, Piaskowski SM, Weisgrau KL, Castrovinci PA, Wilson NA, Ostrowski MA, Park B, Nixon DF, Rakasz EG, Sacha JB.
Abstract
The enormous
sequence diversity of HIV remains a major roadblock to the development
of a prophylactic vaccine and new approaches to induce protective
immunity are needed. Endogenous retrotransposable elements (ERE) such as
endogenous retrovirus K (ERV)-K and long interspersed nuclear element-1
(LINE-1) are activated during HIV-1-infection and could represent
stable, surrogate targets to eliminate HIV-1-infected cells. Here, we
explored the hypothesis that vaccination against ERE would protect
macaques from acquisition and replication of simian immunodeficiency
virus (SIV). Following vaccination with antigens derived from LINE-1 and
ERV-K consensus sequences, animals mounted immune responses that failed
to delay acquisition of SIVsmE660. We observed no differences in acute
or set point viral loads between ERE-vaccinated and control animals
suggesting that ERE-specific responses were not protective. Indeed,
ERE-specific T cells failed to expand anamnestically in vivo following
infection with SIVsmE660 and did not recognize SIV-infected targets in
vitro, in agreement with no significant induction of targeted ERE mRNA
by SIV in macaque CD4+ T cells. Instead, lower infection rates and viral
loads correlated significantly to protective TRIM5α alleles.
Cumulatively, these data demonstrate that vaccination against the
selected ERE consensus sequences in macaques did not lead to
immune-mediated recognition and killing of SIV-infected cells, as has
been shown for HIV-infected human cells using patient-derived
HERV-K-specific T cells. Thus, further research is required to identify
the specific nonhuman primate EREs and retroviruses that recapitulate
the activity of HIV-1 in human cells. These results also highlight the
complexity in translating observations of the interplay between HIV-1
and human EREs to animal models.
No comments:
Post a Comment